Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
about
NRF2, a Key Regulator of Antioxidants with Two Faces towards CancerChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsChemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalitiesSynergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A ReviewPrevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation.Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cellsInhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.Complementary and alternative medications in hepatitis C infection.Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.A non-targeted approach to chemical discrimination between green tea dietary supplements and green tea leaves by HPLC/MS.Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression.ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.The chemopreventive and chemotherapeutic potentials of tea polyphenolsCancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.Epigenetic drugs for cancer treatment and prevention: mechanisms of action.Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha.Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro.Src homology domain-containing phosphatase 2 suppresses cellular senescence in glioblastoma.Catechins and Its Role in Chronic Diseases.(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG-The Role of EGFR Signaling and "Lipid Raft".Green tea (-)-epigallocatechin gallate inhibits IGF-I and IGF-II stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor, but not AMP-activated protein kinase pathway.Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment.Implantation of green tea catechin α-tricalcium phosphate combination enhances bone repair in rat skull defects.Possible Mechanisms of Green Tea and Its Constituents against Cancer
P2860
Q26747249-03FD6D7F-D65D-4ECE-9D18-48B8CF5BE5A0Q26772302-AB9E822C-811E-4228-89B7-B7D4578069B5Q26995915-9E8563BF-A32D-4968-9EB8-FD4C07827689Q28074119-311D4D2D-2BBF-462B-BB14-F5CB19DC24FFQ33754774-0C2A745F-083F-45C1-8F02-4C6FE6146262Q33772886-8CD3B396-D18D-4DD6-8D9B-CE33D1D0854EQ34323180-B033D5A1-B294-4ED3-ACF4-3CA220CE1320Q34411345-626C4658-8BE7-4364-A795-DCF3751843CFQ34635693-B9A6A95C-B39F-4B88-88DE-2116C3A79766Q36691931-9E7C3730-F69B-4E7B-88F8-BEB482D41B43Q37198232-02C0D32C-AC8A-4557-944B-DA629756CCCAQ37269631-764F273A-221C-462E-9685-CF6A68F82363Q37668848-E91CE24A-BFF0-4F3D-B447-B17CE9C1D4C1Q37861787-0CD2CC12-C069-47BC-97F7-16897AAE738DQ37871559-F3897E26-73EB-460D-861E-160BA6B48000Q38093214-D50A35E3-7AC8-4C7E-926B-566C2095089CQ38165918-80702BC2-EA1E-4147-9AC1-E4FD88CD97E9Q38472433-67183F00-2F28-4985-9AFE-483ECF192FD0Q38787044-372B7ADE-47B9-4791-B7B3-0ADC44507B29Q38841650-9E0286E3-25DD-450F-9442-276362FF7D84Q38946471-89399F92-A5E9-496B-BBB0-693F0E03D9CDQ38988558-172488DC-9394-4596-9FC9-E3192E464A84Q39707051-29ACF59D-66A5-4889-BC96-FBDCBC716200Q41273648-94A4B7D6-98CD-49DA-A035-4B8372AC76A8Q42038428-45CDE0F7-A6AE-4BF4-97F1-3B3E95B05825Q42795848-84B8F2E9-2C81-43FA-8B4D-E50F1154AF49Q47103200-026AB359-84E5-435E-89F6-E2E5A69F6DBEQ50098192-215511DC-16AC-4209-8741-7336A08D6BD8Q50520452-A3C29DD1-4FBE-41EA-8F2F-2DF969EE56A3Q58691575-343AE41B-F7BA-444D-8231-9A82D2EA0A72
P2860
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
@en
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
@nl
type
label
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
@en
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
@nl
prefLabel
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
@en
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
@nl
P2093
P2860
P356
P1476
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
@en
P2093
Hisataka Moriwaki
Masahito Shimizu
Yohei Shirakami
P2860
P304
P356
10.3390/IJMS9061034
P407
P577
2008-06-20T00:00:00Z